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Background: Studies that explore the controversial association between parity and anaemia-in-pregnancy (AIP)
were often hampered by not distinguishing incident cases caused by pregnancy from prevalent cases complicated
by pregnancy. The authors’ aim in conducting this study was to overcome this methodological concern.
Methods: A retrospective cohort study was conducted in Oman on 1939 pregnancies among 479 parous female
participants with available pregnancy records in a community trial. We collected information from participants, the
community trial, and health records of each pregnancy. Throughout the follow-up period, we enumerated 684 AIP
cases of which 289 (42.2%) were incident cases. High parity (HP, ≥ 5 pregnancies) accounted for 48.7% of total
pregnancies. Two sets of regression analyses were conducted: the first restricted to incident cases only, and the
second inclusive of all cases. The relation with parity as a dichotomy and as multiple categories was examined for
each set; multi-level logistic regression (MLLR) was employed to produce adjusted models.
Results: In the fully adjusted MLLR models that were restricted to incident cases, women with HP pregnancies had
a higher risk of AIP compared to those who had had fewer pregnancies (Risk Ratio, RR = 2.92; 95% CI 2.02, 4.59);
the AIP risk increased in a dose-response fashion over multiple categories of parity. In the fully adjusted MLLR
models that included all cases, the association disappeared (RR = 1.11; 95% CI 0.91, 1.18) and the dose-response
pattern flattened.
Conclusions: This study shows the importance of specifying which cases of AIP are incident and provides
supportive evidence for a causal relation between parity and occurrence of incidental AIP.
Background
Despite being a major public health issue, anaemia in
pregnancy (AIP) is, surprisingly, still not well under-
stood in terms of its definition, prevalence, incidence,
causes, and the effectiveness of iron supplements in
improving pregnancy outcomes [1].
The uncertainty in defining AIP is a major obstacle in
etiological research of AIP. Researchers show a tendency
to confuse cases of anaemia caused by pregnancy (incident
cases) with pre-existing cases of anaemia complicated by
pregnancy (prevalent cases). This ambiguity stems from
inconsistent systems of measurement criteria for the onset
of anaemia. Some authors considered “a n a e m i aa tf i r s t
antenatal care visit“ as a measure of occurrence of AIP
[2], while others considered any antenatal low hemoglo-
bin (Hb) measurement throughout the course of preg-
nancy [3]. A third subset of reports provide no indication
of which Hb measurement cutoff was used or the specific
timing of onset measurement [4-6].
Ideally, a measure of incident cases of AIP should spe-
cify a point/period in time that is more recent than the
onset of pregnancy and allows for a reasonable latency
period for the causal action of pregnancy in causing
incident AIP. To our knowledge, there is no universal
standard for the exact timing of measurement for the
onset of anaemia that would clearly differentiate
between incident and prevalent cases.
Due to this variation in the definitions of AIP, esti-
mates of the prevalence and incidence of AIP among
pregnant women are uncertain. The World Health
Organization (WHO) estimates the prevalence of
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and 90.2% in developing countries, while in developed
countries it is estimated to be 8.3% [7]. However, many
of these women were already anaemic before being
pregnant. As a matter of fact, the WHO estimates the
prevalence of anaemia to be 47.5% among non-pregnant
women in developing countries and 19% in women in
developed countries [1,7]. Furthermore, the estimated
prevalence of anaemia varies throughout the course of
pregnancy. In the USA, for example, the prevalence of
anemia among pregnant women is estimated to be 1.8%
in the first trimester, 8.2% in the second trimester, and
27.4% in the third trimester [8].
Another factor that adds to the complexity in measur-
ing the incidence of AIP is the variation among
researchers in specifying the cutoff point of Hb level.
While some investigators defined AIP as Hb < 11.0 g/dl
as per the recommendation of the WHO [9,10], others
adopted different cutoff points such as < 10.0 and <
10.5 g/dl which had been recommended by other parties
in the USA [11,12].
High parity is among the factors with etiologic poten-
tial in causing AIP [13]. The WHO defines high parity
(HP) as five or more pregnancies with gestation periods
of ≥ 20 weeks, and low parity (LP) as less than 5 preg-
nancies with gestation periods of ≥ 20 weeks [14].
Prior studies provided inconsistent evidence regarding
the question of whether high parity is associated with
AIP. While some studies found that increasing parity
was associated with an increase in the risk of AIP
[5,6,15,16], others reported no evidence of such an asso-
ciation [4,17-19]. A third group of studies reported a
reduction in risk of AIP [20,21].
This retrospective cohort study was conducted in
order to explore the potential relation between parity
and AIP with special attention to the distinction
between prevalent and incident cases. The population
studied were Omani woman characterized by a high
prevalence of both HP and AIP.
Methods
The study took place in Bidbid, a city located about
30 kilometres west of the capital, Muscat. This study was
conducted in collaboration with an ongoing randomized
community trial named: “Delaying the Development of
Diabetes Mellitus Type 2 in Oman”, also called the
“AMAL study”. This project was launched in 2004, and it
aims to estimate the prevalence of pre-diabetes among an
Omani population and apply appropriate interventions to
prevent the occurrence of diabetes. The AMAL study
e n r o l l e dat o t a lo f1 3 1 3s u b j e c t s ,8 2 4o fw h o mw e r e
women. Among the female enrolees, 283 were nullipar-
ous women and the remaining 541 were parous.
Our target was to enroll the 541 parous women and
to collect relevant information about their pregnancies.
Out of the 541 parous women, 532 (98.3%) agreed to
participate after reviewing an informed consent. The
study was approved by the Medical Research and Ethics
Committee at Sultan Qaboos University.
The participants were asked to fill out a maternal
health card (MHC) with details of all their pregnancies.
These cards were our primary source of information for
antenatal and clinical details pertaining to pregnancies.
MHCs are registry cards that document all the events
that occurred to the mother throughout pregnancy and
after delivery. The cards contain the following sections:
socio-demographics, pre-pregnancy risk factors, past
medical history, obstetric & gynecological history, clini-
cal findings at each visit, investigations, details of deliv-
ery, and post-natal findings.
The participants provided a list of all their pregnancies
and the MHCs. After the exclusion of miscarriages,
twin-pregnancies, and pregnancies < 20 weeks of gesta-
tion, the study’s final population included 1939 singleton
pregnancies with available MHCs among 479 women.
An incident case of AIP was defined as an episode
of plasma hemoglobin level less than 11.0 g/dl first
diagnosed in the second trimester or later, i.e. from
12 weeks onwards. The cutoff point was designated as
11.0 g/dl in accordance with the WHO recommendation
and the local practice in Oman. The 12
th week was spe-
cified as the starting point of the eligible time frame for
incident cases of AIP because it is during the beginning
of the second trimester that pregnancy usually causes
the steepest reduction in Hb level [22]. If a case of anae-
mia was diagnosed at booking or during the first trime-
ster, it was thus considered to be a prevalent case for
the purpose of this study and the pregnancy was
excluded in order to limit the study population to those
at risk of developing AIP.
Initial calculations of the cumulative incidence (risk)
and the average hemoglobin level of occurrence of AIP
were made for each level of parity, every single unit
being treated as a level. The crude and adjusted mea-
sures of the effect of parity on the occurrence of AIP
were obtained by using multi-level logistic regression
(MLLR) analysis [23]. MLLR was preferred for analysis
because it accounts for the dependency that exists
among pregnancies that belong to the same woman.
The MLLR models were developed for AIP as an out-
come using the hierarchical (PROC NLMIXED) regression
modelling of SAS software (with a binomial distribution
and logit link function). Two-level models were con-
structed which allowed for the grouping of pregnancy out-
comes within women in order to include residuals for
each pregnancy and for each woman. Thus the residual
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level, one showing the variance of residuals between differ-
ent women and the second showing the variance of resi-
duals between pregnancies in the same woman. This
bi-level analysis revealed unobserved characteristics that
affect pregnancy outcomes for the same woman, and it
was these unobserved variables which showed the correla-
tion between outcomes for pregnancies in the same
woman. Variables deemed significant at p < 0.20 in a
bivariate model were used i nam u l t i v a r i a t em o d e l .
A backward-selection procedure was then carried out, and
variables meeting the p < 0.10 significance level were
included in the final model. The odds ratios that were pro-
duced by the MLLR approximate the risk ratios which
measure of effect of the relation between parity and AIP.
In all MLLR models, goodness-of-fit was checked by via
examining maximum likelihood estimates. The level of
statistical significance was set at 0.05.
Two series of logistic regression models were con-
ducted with different categorizations of parity. The first
series treated parity as a dichotomous variable: LP (< 5)
and HP (≥ 5). For the second series, parity was included
as a categorical variable with the following categories: 1,
2-3, 4-5, 6-7, 8-9, and ≥ 10. With this categorization, we
were able to evaluate if there was a dose-response rela-
tion between parity and risk of AIP.
Each series of analysis also included two sets of sub-
analyses: a crude model and an adjusted model. In the
crude model, parity was the only predictor of the occur-
rence of AIP. In the adjusted model, the following sig-
nificant confounders were adjusted for: maternal age,
maternal educational status, family income, past history
of AIP, year of delivery, and inter-pregnancy time.
In order to explore the effect of changing the defini-
tion of AIP on the measures of effect of the relation
between parity and AIP, two secondary analyses were
conducted. First, the relationships were re-examined
resetting the cutoff values for anaemia at hemoglobin
levels < 10.5 g/dl and < 10.0 g/dl. Second, the study
population was expanded to include all pregnancies with
available MHCs (1939) and re-examined including these
additional prevalent and incident cases of anaemia. All
statistical analyses were performed using SAS software
version 9.1 (SAS Foundation, Cary, NC).
Results
The study population included 1939 pregnancies among
479 women. However, most of the analyses in this study
excluded 591 of these pregnancies because they were
associated with prevalent rather than incident cases of
AIP. The study thus analysed the 1348 remaining preg-
nancies at risk of developing AIP among 341 women.
Table 1 compares important baseline characteristics of
the included LP and HP pregnancies at the time of each
pregnancy’s occurrence. Out of the 1348 enrolled preg-
n a n c i e s ,3 8 . 7 %w e r eH P ;t h e s et e n d e dt ob ea s s o c i a t e d
with higher maternal age. The majority of HP pregnancies
occurred in women who were 25 to 35 years old, while the
majority of LP pregnancies concerned women who were
20 to 25 years of age. Among HP pregnancies, 30.1% had a
maternal age ≥ 35 years whereas among LP pregnancies
only 2.6% of the women were ≥ 35 years of age.
T h er a t eo fi l l i t e r a c ya m o n gH Pp r e g n a n c i e sw a s
almost three times that of LP pregnancies (58.2% vs.
19.1%). While 62.5% of LP pregnancies occurred in
women who attended standard schools, only 22.5% of
Table 1 Comparison between LP (< 5) and HP (≥ 5)
Pregnancies with available MHCs
LP pregnancies HP pregnancies
Socio-demographic
characteristic
Count Percentage Count Percentage
n 826 61.3 522 38.7
Age
15 to 24 504 61.0 58 11.1
25 to 29 237 28.7 132 25.3
30 to 34 64 7.7 175 33.5
35 to 44 21 2.5 157 30.1
Education
Illiterate 158 19.1 304 58.2
Read only 152 18.4 101 19.3
6
th grade 171 20.7 59 11.3
9
th grade 172 20.8 39 7.5
12
th grade and higher 173 20.9 19 3.6
Monthly family income
(Omani Rials)
< 100 44 5.4 20 3.9
100 to < 200 330 39.9 123 23.6
200 to < 500 366 44.3 300 57.4
500 to < 1000 62 7.4 71 13.5
1000 and above 24 2.9 8 1.5
Year of delivery
Before 1990 106 12.8 50 9.6
1990 to 1994 223 27.0 128 24.5
1995 to 1999 224 27.1 155 29.7
2000 to 2004 228 27.6 157 30.1
2005 and beyond 45 5.4 32 6.1
Past history of AIP 118 14.3 217 41.6
History of hematological
disorders
53 6.4 61 11.7
Inter-pregnancy time
(months)
< 12 85 10.3 47 9.0
13 to 24 262 31.7 174 33.3
25 to 36 277 33.5 175 33.5
37 to 48 110 13.3 70 13.4
49 to 60 49 5.9 27 5.2
> 60 43 5.2 29 5.6
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standard schools.
HP pregnancies were associated with higher family
income compared to LP pregnancies. The proportion of
very low income (< 200 Omani rials) among LP preg-
nancies was 45.3% compared to 27.5% in HP
pregnancies.
Among HP pregnancies, 41.6% had a positive past his-
tory of AIP which was three times that of LP pregnan-
cies (14.3%). The proportion of pregnancies that had a
positive history of hematological disorders in the HP
group was almost twice that in the LP group (11.7% vs.
6.4%). Both LP and HP pregnancies tended to have a
comparable distribution of inter-pregnancy time.
During the follow-up period, a total of 289 incident
cases of AIP were enumerated among the 1348 pregnan-
cies considered to have been at risk. Table 2 details the
mean hemoglobin level and cumulative incidence (risk)
of AIP for each category of parity. Overall, risk of AIP
increases along with parity. The risk starts as high as
19.6 among the primiparous pregnancies. It then slightly
drops over increasing parity units until parity 4, when
the risk begins to increase steadily.
Table 3 shows the results of the first series of analysis,
which treated parity as a dichotomy. The crude model
showed that the risk of developing AIP among the HP
pregnancies was more than four times higher than that
among the LP pregnancies (RR = 4.37; 95% CI 3.32,
5.77). After adjustment for all confounders using MLLR,
the risk of AIP among the HP pregnancies was still
about three times higher (RR = 2.92; 95% CI 2.02, 4.59).
Table 3 also shows the results obtained by analyzing
parity as a categorical variable. Using parity 2-3 as the
reference category, the crude model showed that primi-
parity is associated with an increased risk of AIP (RR =
2.32; 95% CI 1.45, 3.70). As the level of parity increases,
the risk ratios indicate a progressive increase in the risk
of AIP. The highest risk of any parity category is
observed among the parity 8-9 category (RR = 9.98; 95%
CI 6.95, 12.05). The drop in the risk ratio observed in
the parity ≥10 category is likely to be due to sparse data.
Overall, the crude model strongly suggests a positive
dose-response relation between parity and risk of occur-
rence of AIP.
Adjustment for confounders using MLLR showed a
dose-response relation between parity and risk of AIP
similar to that observed in the crude model, with the
highest risk ratio again being observed in the parity 8-9
category (RR = 5.67; 95% CI 3.55, 13.16).
T a b l e4a n dF i g u r e1s h o wt h er e s u l t so ft h es e c o n d -
ary analyses with varying definitions of the outcome.
Over dichotomous parity, the risk ratio increased
slightly, from 2.92 for < 11.0 g/dl to 3.12 for < 10.0 g/dl,
when the cutoffs were lowered. Over multiple categories
of parity, taking < 10.5 g/dl as the cutoff value of the
hemoglobin level produced a similar result pattern to
that found with a cutoff value of 11.0 g/dl, although the
RRs were higher. Taking < 10.0 g/dl as the cutoff value
also produced a similar pattern with an even further
increase in the RRs.
Table 4 also shows the effect of including prevalent
cases of AIP in addition to incident cases. For the cutoff
value of Hb < 11.0 g/dl cutoff value, adding prevalent
cases attenuated the risk of AIP over dichotomous parity
(RR shifted from 2.92 to 1.11). Over multiple categories
Table 2 Crude cumulative incidence (risk) of AIP over single units of parity
Parity hemoglobin level (g/dl) Mean (SD) AIP cases Pregnancies Risk (per 100 pregnancies) 95% CI
1 11.2 (0.9) 41 209 19.6 (14.7, 25.4)
2-3 11.4 (1.0) 44 441 10.0 (6.2, 13.9)
4-5 11.4 (0.9) 30 268 11.2 (9.1, 14.2)
6-7 11.5 (1.0) 57 190 30.0 (26.4, 33.7)
8-9 11.4 (1.0) 66 122 54.1 (49.6, 57.5)
10 and above 11.3 (1.0) 51 118 43.2 (40.1, 47.2)
Total 11.4 (1.0) 289 1348 21.4 (19.3, 23.7)
Table 3 Crude and adjusted logistic regression models




Parity RR 95% CI* RR 95% CI
Dichotomous parity
LP (< 5) 1.00 - 1.00 -
HP (≥ 5) 4.37 (3.32, 5.77) 2.92 (2.02, 4.59)
Categorical parity
1 2.32 (1.45, 3.70) 1.09 (0.48, 1.88)
2-3 1.00 - 1.00 -
4-5 1.20 (0.73, 1.97) 1.14 (0.42, 1.99)
6-7 4.07 (2.61, 6.35) 3.01 (2.06, 7.02)
8-9 9.98 (6.95, 12.05) 5.67 (3.55, 13.16)
≥ 10 7.75 (4.78, 12.55) 4.32 (2.71, 14.25)
* RR refers to Risk Ratio; 95% CI refers to 95% confidence intervals.
† Adjusted for maternal age, educational level, family income level, year of
delivery, past history of AIP, inter-pregnancy time, and past history of
hematological disorders.
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slight increase in the risk of AIP over increasing parity
units. The pattern suggested that including prevalent
cases shifted the RRs towards null. See Figure 1 for
comparison with results obtained from the primary ana-
lysis which was restricted to incident cases.
Discussion
This retrospective population-based cohort study was
conducted in order to explore whether parity has a
harmful effect on the occurrence of AIP. Our results
showed that HP pregnancies carry about three times
higher risk of developing incident AIP than LP pregnan-
cies, and that the risk of AIP increases in a dose-
response fashion over increasing levels of parity.
The greater risk of AIP associated with higher parity
may be explained by women having HP pregnancies’
increased susceptibility to hemorrhage. In a healthy
pregnancy, hormonal changes lead to an increase in
plasma volume which causes reduction in hemoglobin
level [22]. This hemodilution effect is considered normal
if the hemoglobin concentration does not drop below
a certain level e.g. 11.0 g/dl. Compared to the non-
pregnant state, every pregnancy carries an increased risk
of hemorrhage before, during, and after delivery. There-
fore, higher parity exposes women more frequently to
periods of hemorrhage risk. Although there is no con-
sensus with regard to the exact mechanisms by which
HP increases the risk of hemorrhage, some reports have
suggested intermediaries such as increased venous drai-
nage to the lower part of the uterus, hyalinization of
blood vessels, and decreased elasticity of the uterine wall
[24]. None of these proposed mechanisms have been
confirmed [14].
Primiparous pregnancies were found to be at a higher
risk of AIP compared to pregnancies with parity of 1
to 2. High rates of AIP among primiparous pregnancies
are commonly found to be associated with adolescence
and smoking [25]. Our finding could be explained by
being adolescent as the majority (71.2%) were associated
with a maternal of less than 20 years. Other risk factors
such as active or passive smoking are unlikely to play a
role since none of the women in our study reported
active smoking, and the prevalence of smoking in our
source population was 6.3%.
The study’s results showed that the association between
HP and AIP became more pronounced when the specifi-
city of the definition of AIP was increased by lowering the
diagnostic cutoff value. This finding emphasizes the
importance of specifying an appropriate diagnostic cutoff
value for AIP. Because one of the objectives of the antena-
tal care services is early detection of anemia in the course
of pregnancy, some authorities, such as the WHO, recom-
mend a high cutoff value in order to increase the sensitiv-
ity of the screening tests and thereby increase their ability
Table 4 Secondary adjusted analyses with varying definitions of the outcome (AIP)
All cases (prevalent & incident) Incident cases only
Hb < 11.0 g/dl Hb < 10.5 g/dl Hb < 10.0 g/dl
Parity RR
† 95% CI* RR
† 95% CI RR
† 95% CI RR
† 95% CI
LP 1.00 - 1.00 - 1.00 - 1.00 -
HP 1.11 (0.91, 1.18) 2.92 (2.02, 4.59) 2.97 (1.93, 4.91) 3.12 (1.87, 5.25)
1 1.20 (0.92, 1.66) 1.09 (0.48, 1.88) 1.32 (0.63, 4.13) 1.97 (1.01, 12.03)
2-3 1.00 - 1.00 - 1.00 - 1.00 -
4-5 0.89 (0.55, 1.58) 1.14 (0.42, 1.99) 1.47 (0.41, 3.24) 1.76 (0.27, 5.78)
6-7 1.15 (0.58, 2.00) 3.01 (2.06, 7.02) 3.94 (1.52, 7.89) 4.35 (1.06, 14.57)
8-9 1.13 (0.30, 1.99) 5.67 (3.55, 13.16) 8.63 (2.70, 13.62) 9.73 (2.21, 29.61)
≥ 10 1.19 (0.41, 2.46) 4.32 (2.71, 14.25) 7.18 (2.54, 14.05) 8.05 (1.97, 26.04)
* 95% CI refers to 95% confidence intervals.
† RR obtained from MLLR in which we adjusted for maternal age, educational level, family monthly income level, year of delivery, past history of AIP,
inter-pregnancy time, and past history of hematological disorders.
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Parity
Figure 1 Results of adjusted analyses with varying definition of
the outcome (AIP).
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this recommendation in clinical practice, it is counter-
productive for etiologic research. Adopting high diagnostic
cutoff values reduces the specificity of the diagnostic test
and increases the rate of false positives in the study, result-
ing in misclassification of the outcome via a form of infor-
mation bias. In the present study, the results obtained
with high cutoff values were shifted towards a null risk
ratio because the misclassified outcome was non-differen-
tial over the categories of parity.
This study also found that including prevalent cases in
the analysis tended to conceal the observed association
between parity and AIP to disappear and flatten the
dose-response curve. This finding may be explained by
the fact that treating prevalent cases as incident cases
reduces the specificity of the test, which again leads to a
misclassified outcome. Since this misclassification
occurred non-differentially over the LP and HP groups,
the measures of effect were again shifted towards null
[26].
Most of the previous studies did not adequately spe-
cify the timing and diagnostic cutoff value of AIP [3-6].
The main reason for this appears to be that those stu-
dies did not treat AIP as the main outcome, but rather
listed it among many other antenatal complications.
Their results thus provided inconsistent evidence of
whether HP is associated with an increased risk of AIP.
While some studies provided information about their
diagnostic criteria; however, significant methodological
differences render any comparison of their findings with
our results complex and generally unenlightening.
Among these studies, the study conducted by Bugg
et al. appears to have been the most comprehensive [2]:
it was an age-matched retrospective cohort study in
the United Kingdom conducted on a population of
794 women using two criteria to define of AIP cases:
1) booking Hb < 10.0 g/dl; and 2) any antenatal Hb <
10.0 g/dl. Beyond matching for age, there was no adjust-
ment for confounders. With both definitions, an
increased risk of AIP was found among HP women. The
findings reported by Bugg et al. agree with our finding
of an increased risk of AIP with HP; this agreement may
be attributable to both studies’ adoption of a highly spe-
cific definition of AIP.
The results of the present study are not without
assumptions. By considering only pregnancies that had
reached the 12
th week of gestation, we implicitly
hypothesized a latency period of 12 weeks for the action
of parity. This hypothesis might not be correct. None-
theless, if the actual latency period is longer than
12 weeks, we would infer that our results were affected
by non-differential misclassification of the outcome and
were biased towards null. If this is the case, then actual
measurements of the effect of parity would likely reveal
an even higher risk of AIP among HP compared to LP
pregnancies. On the other hand, the actual latency per-
iod is unlikely to be shorter than 12 weeks because the
physiological mechanisms through which parity induces
AIP, e.g. hemodilution and hemorrhage, have limited
action before the second trimester [22].
Our results may have been affected by selection bias
due to the exclusion of pregnancies with missing MHCs
from the analysis. The possible existence and magnitude
of such a selection bias was assessed by conducting a
parallel analysis of pregnancies occurring only in women
with no missing MHCs (data not shown). The results
suggested a dose-response relation similar to that
observed in the analysis of all pregnancies; it was there-
fore concluded that the impact of this selection bias, if
any, was insubstantial.
Conclusions
In conclusion, increasing parity appears to increase the
risk of occurrence of AIP in a dose-response fashion.
This study shows the importance of differentiating pre-
valent and incident cases of AIP. Inclusion of prevalent
cases shifts the association towards the null and flattens
the dose-response relation. Finally, the study shows the
importance of clearly specifying a diagnostic cutoff value
of hemoglobin level in defining AIP, as increased specifi-
city of the definition enhanced the observed association.
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